Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2/M phase arrest

Hui Li1, Fusheng Zhou1, Hongyan Wang1

  • 1Department of Dermatology, Institute of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, People's Republic of China.

Insights

Targeting eukaryotic translation initiation factor 3, subunit D (EIF3D) with small interfering RNA (siRNA) effectively inhibits melanoma cell survival. Silencing EIF3D causes cell cycle arrest and reduces proliferation, offering a potential gene-targeted therapy for melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Skin cancer, particularly melanoma, is a prevalent malignancy with increasing incidence.
  • Advanced melanoma exhibits resistance to conventional therapies, necessitating novel treatment strategies.
  • Eukaryotic translation initiation factor 3, subunit D (EIF3D) role in melanoma progression requires elucidation.

Purpose of the Study:

  • To investigate the therapeutic potential of silencing EIF3D using small interfering RNA (siRNA) in melanoma.
  • To determine the impact of EIF3D knockdown on melanoma cell survival and proliferation.
  • To analyze the effect of EIF3D inhibition on melanoma cell cycle progression.

Main Methods:

  • Lentivirus-mediated RNA interference was used to achieve EIF3D knockdown in A375 and A431 melanoma cell lines.
  • Cell proliferation was assessed using methylthiazole tetrazolium (MTT) and colony formation assays.
  • Cell cycle progression was analyzed via flow cytometry.

Main Results:

  • siRNA-mediated EIF3D knockdown significantly reduced both gene and protein expression of EIF3D in melanoma cells.
  • EIF3D knockdown resulted in a substantial decrease in melanoma cell proliferation.
  • Inhibition of EIF3D induced a G2/M phase cell cycle arrest in melanoma cells.

Conclusions:

  • EIF3D plays a critical role in the survival and progression of melanoma cells.
  • Depletion of EIF3D demonstrates significant anti-melanoma effects.
  • Targeting EIF3D represents a promising therapeutic strategy for gene-targeted melanoma treatment.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
32.1K